We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RUN:NASDAQSunrun Inc. Analysis

Data as of 2026-08-31 - not real-time

$8.67

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Sunrun Inc. is bearish at $8.66, with short-term averages lagging the long-term ones. It has lost 24.3% over the past 30 days. With RSI at 35.4 the momentum picture is approaching oversold, alongside a bearish MACD signal. Price has been bracketed by support at $8.58 and resistance at $11.19.
On valuation the read is undervalued — earnings multiple of 5.9 versus a 35.6 sector average, below the peer group. Analyst price targets sit 84.3% above the current price. Revenue is growing at 52.8% on a 11.6% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 67.1%, a beta of 2.79 and a maximum drawdown of 59.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

SAN FRANCISCO AP — SAN FRANCISCO AP — Sunrun Inc.Residential solar energy company Sunrun NASDAQ:RUN reported revenue ahead of Wall Street’s expectations in Q2 CY2026,...Sunrun’s latest internal fair value estimate has shifted from US$18.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 14.70
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 5.9 versus sector average of 35.6
  • Trading below the 200-day average of 14.70

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 5.9 versus sector average of 35.6
  • Analyst targets imply +84.3% versus the current price
  • Negative return on equity of -19.9%

Key Metrics & Analysis

Financial Health

Revenue Growth52.80%
Profit Margin11.59%
P/E Ratio5.9
ROE-19.86%
ROA0.26%
Debt/Equity292.51
P/B Ratio0.6
Op. Cash Flow$-200131008
Free Cash Flow$-1971139840
Industry P/E35.6

Technical Analysis

TrendBearish
RSI35.4
Support$8.58
Resistance$11.19
MA 20$9.60
MA 50$10.99
MA 200$14.70
MACDBearish
VolumeDecreasing
Fear & Greed Index94.38

Valuation

Target Price$15.97
Upside/Downside84.35%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.79
Volatility67.10%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.